Everest Group, Ltd. EG 深滬

等待開盤 01-14 09:30:00 美东时间

319.02

-9.360

-2.85%

華盛通

立即下載

最高328.26
今開328.15
成交量 22.47万股
最低 317.21
昨收 328.38
總市值 133.92亿
52周最高 366.29
市盈率 ^靜 10.03
換手率 0.00%
52周最低 300.44
委比 -85.15%
總股本 4197.81万
歷史最高 400.42
量比 0.67
振幅 3.37%
歷史最低 3.48
每手 1
風險率 12.54%

個股概要

財務分析

公司資料

分紅派息

分時圖
日k
周k
月k

相關新聞

美股大行评级 | 潜在涨幅197.4%！奥麦罗制药获HC Wainwright升目标价至40美元，维持"买入"评级

今日重点评级关注：HC Wainwright & Co.：维持奥麦罗制药"买入"评级，目标价从20美元升至40美元；HC Wainwright & Co.：维持Cullinan Therapeutics"买入"评级，目标价从26美元升至27美元

01-09 20:22
美股大行评级 | 拼多多、小鹏获Freedom上调目标价；多家大行首予Wealthfront"超配"评级，目标价最高23美元

今日重点评级关注：HC Wainwright & Co.：维持MetaVia Inc."买入"评级，目标价从12美元升至40美元；Canaccord Genuity：维持GH Research"买入"评级，目标价从35美元升至39美元

01-07 17:25
Keefe, Bruyette & Woods Maintains Outperform on Everest Group, Raises Price Target to $430

Keefe, Bruyette & Woods analyst Meyer Shields maintains Everest Group (NYSE:EG) with a Outperform and raises the price target from $400 to $430.

01-07 01:31
美股大行评级 | 潜在涨幅263.64%！Milestone Pharmaceuticals获富国银行升目标价至8美元，维持"超配"评级

今日重点评级关注：富国银行：维持Milestone Pharmaceuticals"超配"评级，目标价从4美元升至8美元；富国银行：维持Kyverna Therapeutics"超配"评级，目标价从31美元升至33美元

2025-12-17 10:46
美股大行评级 | 潜在涨幅113%！麦格理首予小马智行“跑赢大市"评级目标价29美元；Roth Capital下调好市多至"卖出"，目标价从906美元降至769美元

今日重点评级关注：HC Wainwright & Co.：维持BioCryst Pharma"买入"评级，目标价从30美元升至32美元；TD Cowen：上调Milestone Pharmaceuticals评级至"买入"，目标价8美元

2025-12-16 09:36
TD Cowen Maintains Hold on Everest Group, Lowers Price Target to $365

TD Cowen analyst Andrew Kligerman maintains Everest Group (NYSE:EG) with a Hold and lowers the price target from $400 to $365.

2025-12-16 00:31
These 10 S&P 500 Stocks Are Dirt Cheap This Black Friday

These 10 S&P 500 stocks are trading at the lowest forward P/E ratios heading into Black Friday 2025 — and analysts see major upside ahead.

2025-11-28 23:12
Everest Group Appoints Elias Habayeb Group CFO, Effective Around May 1, 2026, Succeeding Mark Kociancic

Everest Group, Ltd. (NYSE: EG), a global underwriting leader providing world-class reinsurance and specialty insurance solutions, today announced the appointment of Elias Habayeb as EVP and Group Chief Financial Officer,

2025-11-21 05:17
美股大行评级 | 高盛上调英伟达目标价升至240美元； Loop Capital上调英伟达目标价升至350美元！

今日重点评级关注：花旗：维持Caribou Biosciences"买入"评级，目标价从5美元升至8美元；HC Wainwright & Co.：上调MoonLake Immunotherapeutics - Class A Ordinary Shares评级至"买入"，目标价30美元

2025-11-04 10:31

派息除權日	每股總股息	派息日期
2025-11-26	2.00	2025-12-12
2025-09-03	2.00	2025-09-19
2025-05-28	2.00	2025-06-13
2025-03-17	2.00	2025-03-28
2024-11-27	2.00	2024-12-13
2024-09-16	2.00	2024-09-27
2024-05-29	2.00	2024-06-14
2024-03-18	1.75	2024-03-27
2023-11-28	1.75	2023-12-15
2023-09-18	1.75	2023-09-29
2023-05-30	1.65	2023-06-16
2023-03-15	1.65	2023-03-30
2022-11-22	1.65	2022-12-16
2022-08-23	1.65	2022-09-09
2022-05-24	1.65	2022-06-17
2022-03-15	1.55	2022-03-30
2021-11-30	1.55	2021-12-22
2021-08-24	1.55	2021-09-15
2021-05-25	1.55	2021-06-09
2021-03-16	1.55	2021-03-31
2020-12-01	1.55	2020-12-23
2020-09-01	1.55	2020-09-16
2020-05-26	1.55	2020-06-10
2020-03-10	1.55	2020-03-30
2019-12-03	1.55	2019-12-24
2019-09-03	1.40	2019-09-18
2019-05-28	1.40	2019-06-12
2019-03-05	1.40	2019-03-20
2018-11-27	1.40	2018-12-12
2018-09-04	1.30	2018-09-19
2018-05-29	1.30	2018-06-13
2018-03-06	1.30	2018-03-21
2017-11-28	1.30	2017-12-13
2017-09-01	1.25	2017-09-20
2017-05-26	1.25	2017-06-14
2017-03-06	1.25	2017-03-22
2016-11-28	1.25	2016-12-14
2016-09-02	1.15	2016-09-21
2016-05-27	1.15	2016-06-15
2016-03-07	1.15	2016-03-23
2015-11-30	1.15	2015-12-16
2015-08-24	0.95	2015-09-09
2015-06-01	0.95	2015-06-17
2015-03-09	0.95	2015-03-25
2014-12-01	0.95	2014-12-17
2014-08-25	0.75	2014-09-10
2014-06-02	0.75	2014-06-18
2014-03-10	0.75	2014-03-26
2013-12-02	0.75	2013-12-18
2013-08-26	0.48	2013-09-18
2013-06-03	0.48	2013-06-19
2013-03-04	0.48	2013-03-20
2012-11-26	0.48	2012-12-12
2012-08-27	0.48	2012-09-19
2012-05-25	0.48	2012-06-13
2012-03-05	0.48	2012-03-21
2011-11-28	0.48	2011-12-14
2011-08-29	0.48	2011-09-14
2011-05-27	0.48	2011-06-15
2011-03-07	0.48	2011-03-23
2010-11-29	0.48	2010-12-15
2010-08-30	0.48	2010-09-15
2010-05-28	0.48	2010-06-16
2010-03-08	0.48	2010-03-24
2009-11-30	0.48	2009-12-16
2009-08-31	0.48	2009-09-16
2009-05-22	0.48	2009-06-10
2009-03-02	0.48	2009-03-18
2008-11-20	0.48	2008-12-15
2008-08-21	0.48	2008-09-15
2008-05-21	0.48	2008-06-16
2008-02-28	0.48	2008-03-17
2007-11-28	0.48	2007-12-21
2007-09-04	0.48	2007-09-21
2007-06-01	0.48	2007-06-22
2007-03-01	0.48	2007-03-23
2006-11-22	0.24	2006-12-15
2006-08-24	0.12	2006-09-15
2006-05-24	0.12	2006-06-16
2006-03-02	0.12	2006-03-24
2005-11-23	0.11	2005-12-16
2005-08-25	0.11	2005-09-16
2005-05-25	0.11	2005-06-17
2005-03-03	0.11	2005-03-25
2004-11-24	0.10	2004-12-17
2004-08-26	0.10	2004-09-17
2004-05-26	0.10	2004-06-18
2004-02-26	0.10	2004-03-19
2003-11-24	0.09	2003-12-19
2003-08-27	0.09	2003-09-19
2003-05-29	0.09	2003-06-20
2003-02-27	0.09	2003-03-21
2002-11-27	0.08	2002-12-20
2002-08-28	0.08	2002-09-20
2002-05-30	0.08	2002-06-21
2002-02-28	0.08	2002-03-22
2001-11-19	0.07	2001-12-21
2001-08-29	0.07	2001-09-21
2001-05-31	0.07	2001-06-22
2001-03-02	0.07	2001-03-23
2000-11-28	0.06	2000-12-21
2000-08-30	0.06	2000-09-22
2000-06-02	0.06	2000-06-22
2000-03-06	0.06	2000-03-30
1999-11-29	0.06	1999-12-22
1999-09-01	0.06	1999-09-24
1999-06-03	0.06	1999-06-25
1999-03-04	0.06	1999-03-26
1998-11-27	0.05	1998-12-18
1998-09-01	0.05	1998-09-24
1998-06-03	0.05	1998-06-26
1998-03-05	0.05	1998-03-27
1997-11-28	0.04	1997-12-19
1997-09-08	0.04	1997-09-26
1997-06-06	0.04	1997-06-27
1997-03-05	0.04	1997-03-27
1996-12-02	0.03	1996-12-19
1996-08-30	0.03	1996-09-19
1996-06-03	0.03	1996-06-20
1996-02-14	0.03	1996-03-15
1995-11-16	0.03	1995-12-04

公司名稱	Everest Group Ltd.
行業分類	Property/Casualty Insurance
業務描述	Everest Re Group, Ltd.成立于1999年，是控股公司的全资子公司。公司的主要业务是在美国、百慕大和国际市场承保再保险和保险业务。

Everest Group, Ltd. EG 深 滬

319.02

個股概要

財務分析

公司資料

相關新聞

分紅派息

相關新聞

公司簡介

Everest Group, Ltd. EG 深滬